Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)
Phase 4
Completed
- Conditions
- Hygiene
- Registration Number
- NCT00497783
- Lead Sponsor
- Sanofi
- Brief Summary
The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Femina Delicata.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
- Integral skin in the tested region
Exclusion Criteria
- Pregnancy or breastfeeding women
- Use of Anti-inflammatory or immune-suppression drugs
- Topical medication use at the tested region
- Active cutaneous gynaecological disease which may interfere in study results
- Personal history of allergic disease at the area to be treated
- Allergic or atopic history
The above information is not intended to contain considerations relevant to a patient's potential participation in a clinical trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Clinical and local tolerability 21 days Adverse events and their association with the treatment. 21 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sanofi-aventis
🇧🇷São Paulo, Brazil